This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
These are heady times for using artificialintelligence to extract insights from healthcare data—in particular, from the tidal wave of information coming out of fields like genomics and medical imaging. This story is part of an ongoing Xconomy series on A.I. in healthcare.
Three, local venturecapital investors -- Miramar Venture Partners , Okapi VentureCapital , and Qualcomm Ventures -- are part of a group investing $22.1M The investment is the first out of IBM''s $100M "Watson Fund", which aims to invest in companies using its Watson artificialintelligence software.
This week, we’re focusing on artificialintelligence, one of the buzziest fields in tech. Or, maybe instead, it’s a day filled with long lunches and listless Internet surfing, as you seek out all the interesting articles you missed during the week. Here are a. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
Artificialintelligence innovation has become part of our everyday lives—retailers use it to tailor the product recommendations they make; biotech companies hope it can create customized medicine. But its shortcomings, born of human biases, are becoming apparent as well. A new organization called Ada-AI, which is based in.
[ Updated 12/27/18, 9:54 am ] Manoj Saxena is bullish on artificialintelligence. startup CognitiveScale and managing director of The Entrepreneur Fund , which makes investments in early-stage machinelearning companies, Saxena believes A.I. As chairman of Austin, TX-based A.I.
The startup, led by Ryan Detert, says it helps marketers reach more than 7,000 top influencers on Facebook, Instagram, Snapchat, Twitter, Vine and YouTube, using artificialintelligence technology from IBM Watson. The company says it has now raised a total of $9M.
Artificialintelligence and cybersecurity remained front and center in tech, as new. Storylines in various sectors helped shape the overall narrative in 2018. Cell and gene therapies, cancer immunotherapy, and digital medicines made substantial progress in healthcare. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
Entrepreneur-turned-venture capitalist Vinod Khosla made big headlines almost six years ago when he wrote a blog post called “Do We Need Doctors or Algorithms?” It’s been quite a ride since then.
Artificialintelligence is poised to infiltrate nearly all aspects of human life. Given this development, technologists are focusing on how to ensure the technology usage is governed by ethics. The general rule is that power begets responsibility,” says Michael Stewart, founder and CEO of Lucid AI , an AI startup in Austin. “If
The conference is run by Jamie Montgomery , one of the local industry's pioneers in venturecapital and investment. We're also excited about the areas around artificialintelligence for certain verticals. If you think about all the things you need for autonomous vehicles, it's all here in LA.
Intellectual Ventures’ Nathan Myhrvold. Nobel Laureate David Baltimore. Microbiome AND supercomputer pioneer Larry Smarr. Nicole Glaros of Techstars. These are just a few of the visionary speakers who will be headlining Xconomy’s sixth annual Napa Summit.
—IBM’s Watson Health group said that a commercial product could arrive in 2017 that uses machinelearning to digest patient scans, medical records, and other information to help doctors with care decisions.
There is no Obamacare replacement, at least not as of this writing. The Senate Republicans are fractured, with a handful of conservatives and moderates each giving a cold shoulder to their chamber’s version of healthcare reform, the Better Care Reconciliation Act.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content